SCHEMBL9686167

SCHEMBL9686167

O=C(NC(=O)c1c(O)cccc1F)Nc1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.54
NPC1 O15118 2/20 0.54
GAA P10253 2/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CNR1 P21554 6/20 0.48
PPIA P62937 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 1/20 0.45
MAPT P10636 1/20 0.44
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
TYK2 P29597 1/20 0.44
PYGL P06737 1/20 0.43
PKM P14618 1/20 0.43
F10 P00742 1/20 0.43
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diflubenzuron SCHEMBL42416 0.91 RAB9A (0.59) RAB9ANPC1GAAMEN1KMT2A
Diflubenzuron SCHEMBL18837607 0.91 RAB9A (0.59) RAB9ANPC1GAAMEN1KMT2A
SCHEMBL9324631 0.89 RAB9A (0.57) RAB9ANPC1GAAMEN1KMT2A
Diflubenzuron SCHEMBL8729691 0.87 NPC1 (0.56) RAB9ANPC1GAAMEN1KMT2A
SCHEMBL10711203 0.87 RAB9A (0.56) RAB9ANPC1GAAMEN1KMT2A
Diflubenzuron SCHEMBL28169066 0.86 NPC1 (0.54) RAB9ANPC1GAAMEN1KMT2A
Clanfenur SCHEMBL93573 0.82 RAB9A (0.50) RAB9ANPC1GAAMEN1KMT2A
SCHEMBL9688121 0.82 KMT2A (0.60) RAB9ANPC1GAAMEN1KMT2A
Clanfenur SCHEMBL29356092 0.82 RAB9A (0.50) RAB9ANPC1GAAMEN1KMT2A
SCHEMBL10608014 0.81 MAOA (0.51) RAB9ANPC1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166180-A Administering diphenyl substituted (thio)carbonyl(thio)urea derivatives DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1992-11-24 US disclosed
EP-0324521-A2 Method of treating haematologic diseases and pharmaceutical compositions to be used therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1989-07-19 EP disclosed